MENS Strangle Strategy
MENS (Jyong Biotech Ltd. Ordinary Shares), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Jyong Biotech Ltd. is a Taiwan-based biotech firm focused on developing and commercializing plant-derived drugs targeting urinary system diseases. The company operates through its subsidiaries—Health Ever Bio-Tech, Genvace, and others—working on drug candidates like MCS‑2 (for BPH) currently in Phase III, PCP (for prostate cancer) in Phase II, and IC in pre-clinical stages
MENS (Jyong Biotech Ltd. Ordinary Shares) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $153.6M, a beta of 2.62 versus the broader market, a 52-week range of 1.43-67, average daily share volume of 202K, a public-listing history dating back to 2025, approximately 31 full-time employees. These structural characteristics shape how MENS stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 2.62 indicates MENS has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a strangle on MENS?
A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.
Current MENS snapshot
As of May 15, 2026, spot at $2.02, ATM IV 17.60%, expected move 5.05%. The strangle on MENS below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this strangle structure on MENS specifically: IV rank is unavailable in the current snapshot, so regime-based timing for MENS is inferred from ATM IV at 17.60% alone, with a market-implied 1-standard-deviation move of approximately 5.05% (roughly $0.10 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated MENS expiries trade a higher absolute premium for lower per-day decay. Position sizing on MENS should anchor to the underlying notional of $2.02 per share and to the trader's directional view on MENS stock.
MENS strangle setup
The MENS strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With MENS near $2.02, the first option leg uses a $2.12 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed MENS chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 MENS shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $2.12 | N/A |
| Buy 1 | Put | $1.92 | N/A |
MENS strangle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.
MENS strangle payoff curve
Modeled P&L at expiration across a range of underlying prices for the strangle on MENS. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use strangle on MENS
Strangles on MENS are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the MENS chain.
MENS thesis for this strangle
The market-implied 1-standard-deviation range for MENS extends from approximately $1.92 on the downside to $2.12 on the upside. A MENS long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. As a Healthcare name, MENS options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to MENS-specific events.
MENS strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. MENS positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move MENS alongside the broader basket even when MENS-specific fundamentals are unchanged. Always rebuild the position from current MENS chain quotes before placing a trade.
Frequently asked questions
- What is a strangle on MENS?
- A strangle on MENS is the strangle strategy applied to MENS (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With MENS stock trading near $2.02, the strikes shown on this page are snapped to the nearest listed MENS chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are MENS strangle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the MENS strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 17.60%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a MENS strangle?
- The breakeven for the MENS strangle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current MENS market-implied 1-standard-deviation expected move is approximately 5.05%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a strangle on MENS?
- Strangles on MENS are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the MENS chain.
- How does current MENS implied volatility affect this strangle?
- Current MENS ATM IV is 17.60%; IV rank context is unavailable in the current snapshot.